Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.64 |
| ▸ | NPY2R | P49146 | 1/20 | 0.64 |
| ▸ | NPY4R | P50391 | 1/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.64 |
| ▸ | GLP1R | P43220 | 11/20 | 0.63 |
| ▸ | ECE1 | P42892 | 1/20 | 0.60 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.60 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.60 |
| ▸ | CALCA | P06881 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.59 |
| ▸ | GCGR | P47871 | 4/20 | 0.59 |
| ▸ | GIPR | P48546 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30843895 | 0.93 | NPY1R (0.69) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30843901 | 0.91 | GLP1R (0.65) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30843899 | 0.90 | CXCR4 (0.63) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30666385 | 0.90 | NPY1R (0.69) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30658244 | 0.90 | NPY2R (0.76) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30843900 | 0.89 | CALCA (0.62) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL31683347 | 0.89 | NPY2R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30256968 | 0.88 | NPY1R (0.66) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL29382733 | 0.88 | C5AR1 (0.63) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30721554 | 0.87 | NPY2R (0.76) | NPY1RNPY2RNPY4RNPY5RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117603309-A | Peptides for the treatment of cancer and uses thereof | 主流源生物科技(上海)有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117603309-A | Peptides for the treatment of cancer and uses thereof | 主流源生物科技(上海)有限公司 | 2024-02-27 | — | — | CN | disclosed |